Pharmacokinetics and Pharmacodynamics of Biosimilar Insulins: Is Clamp Technology Fit for Purpose?
Author:
Affiliation:
1. Institute for Cellular Medicine-Diabetes, Newcastle University, Newcastle upon Tyne, U.K.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://diabetesjournals.org/care/article-pdf/38/12/2234/623047/dc151046.pdf
Reference15 articles.
1. Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man;Home;Diabetes Care,1983
2. The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique;Gardner;J Clin Endocrinol Metab,1986
3. The action profiles of human NPH insulin preparations;Starke;Diabet Med,1989
4. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients;Home;Diabetes Care,1998
5. U.S. Food and Drug Administration. Scientific considerations in demonstrating biosimilarity to a reference product [Internet], 2012. Available from www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291128.pdf. Accessed 13 August 2014
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of Unsuppressed Endogenous Insulin on Pharmacokinetics and/or Pharmacodynamics of Study Insulin in the Healthy: A Retrospective Study;Clinical Pharmacology in Drug Development;2022-04-05
2. Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study;Frontiers in Pharmacology;2021-12-02
3. Biosimilars: A novel perspective in diabetes therapy;Asian Pacific Journal of Tropical Medicine;2020
4. Thérapeutique des désordres glycémiques;Diabetologie;2019
5. Pharmacokinetic and Pharmacodynamic Assessment of Novel and Biosimilar Insulins;Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3